Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Cryopreservation Market

Cell Cryopreservation Market Trends

Report ID: GMI7882
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Cell Cryopreservation Market Trends

The cell cryopreservation field is witnessing a notable trend towards the integration of automation in its processes. This advancement is contributing to more precise and reproducible results. Automated systems are playing a pivotal role in streamlining workflows, mitigating human error, and enhancing overall efficiency, particularly in the realms of cell banking and storage.

Simultaneously, ongoing research efforts are dedicated to refining cryopreservation technologies. This involves the exploration and development of novel cryoprotectants and freezing techniques. The aim is to improve the viability and functionality of preserved cells, addressing challenges and optimizing the processes involved in safeguarding cellular materials for various applications in research, medicine, and biotechnology.
The development of novel freezing media that optimize cell viability during the freezing and thawing process is a significant trend. These innovations aim to enhance the overall success of cryopreservation procedures.
These research endeavors reflect a commitment to advancing the capabilities of cryopreservation, ultimately contributing to the broader goals of scientific and medical innovation.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The cell cryopreservation industry was valued at USD 10.4 billion in 2023 and is estimated to reach USD 57.6 billion by 2032, driven by the emergence of new applications for stem cells in disease treatment, augmented investment in the management of chronic diseases, the rising acceptance of stem cell therapeutics, etc.

The equipment segment garnered USD 7.5 billion in 2023 and is growing significantly through 2032 as automated systems are gaining prominence for their ability to streamline workflows, minimize manual errors, and significantly enhance the overall efficiency of processes related to cell banking and storage.

U.S. cell cryopreservation market accounted for USD 4.3 billion in 2023 and is predicted to witness substantial growth over 2024-2032 as the nation is a global hub for biotechnology and pharmaceutical research and development.

Thermo Fisher Scientific Inc., Sartorius AG, PromoCell GmbH, BioLife Solutions Inc., Merck KGaA, HiMedia Laboratories, Creative Biolabs, Corning Incorporated, GE Healthcare, and Danaher Corporation.